Maybe a slight dip in hunger, maybe not
Such statements include, but are not limited to, statements regarding the offerings and services accessible on our platform, statements regarding future collaborations, functionality or expanded access to treatment options
Knowing which drugs carry the weight-loss indication matters because it affects insurance coverage, manufacturer savings card eligibility, and which treatment plan your healthcare provider can prescribe
doi: 10.1007/s00296-016-3481-8 95 BinduSMazumderSBandyopadhyayU
On average, volunteers in the retatrutide clinical trial who received the study drug rather than a placebo lost an average of 70.3 pounds over about a year-and-a-half, with more than 45% of participants losing more than 30% of their body weight
Like semaglutide and tirzepatide, it is a glucagon-like peptide-1 (GLP-1) agonist, meaning it acts on GLP-1 receptors just like the natural GLP-1 hormone in your body